Cargando…
Intranasal Allopregnanolone Confers Rapid Seizure Protection: Evidence for Direct Nose-to-Brain Delivery
Allopregnanolone, a positive modulator of GABA(A) receptors with antiseizure activity, has potential in the treatment of seizure emergencies. Instillation of allopregnanolone in 40% sulfobutylether-β-cyclodextrin into the nose in mice rapidly elevated the seizure threshold in the timed intravenous p...
Autores principales: | Zolkowska, Dorota, Wu, Chun-Yi, Rogawski, Michael A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116426/ https://www.ncbi.nlm.nih.gov/pubmed/33405197 http://dx.doi.org/10.1007/s13311-020-00985-5 |
Ejemplares similares
-
Perampanel, a potent AMPA receptor antagonist, protects against tetramethylenedisulfotetramine-induced seizures and lethality in mice: comparison with diazepam
por: Zolkowska, Dorota, et al.
Publicado: (2021) -
Tolerability and pharmacokinetics of intravenous allopregnanolone with and without midazolam pretreatment in two healthy dogs
por: Bruun, Donald A., et al.
Publicado: (2023) -
Intranasal Nanoemulsions for Direct Nose-to-Brain Delivery of Actives for CNS Disorders
por: Bahadur, Shiv, et al.
Publicado: (2020) -
4512 Allopregnanolone Dose Finding for Status Epilepticus Treatment by Pharmacokinetic-Pharmacodynamic Modeling using Quantitative EEG in Dogs
por: Patterson, Edward “Ned”, et al.
Publicado: (2020) -
Intranasal Zolmitriptan-Loaded Bilosomes with Extended Nasal Mucociliary Transit Time for Direct Nose to Brain Delivery
por: El Taweel, Mai M., et al.
Publicado: (2021)